Eastman Chemical Co. (EMN) Pops 2.53% for January 26

Equities Staff |

One of the S&P 500’s big winners for Tuesday January 26 was Eastman Chemical Co. ($EMN) as the company’s stock climbed 2.53% to $62.30 on volume of 1.08 million shares.

The stock opened at $60.91 and saw an intraday low of $60.63 and an intraday high of $62.51. All told, the day saw a per-share gain of $1.54. The stock’s average daily volume of 1.26 million and 148.61 million shares outstanding. Eastman Chemical Co. now has a 50-day SMA is $67.42 and 200-day SMA is $72.23, and it has a 52-week high of $83.90 and a 52-week low of $58.85.

Eastman Chemical Co is a specialty chemical company which manufactures and sells a portfolio of chemicals, plastics and fibers. It has eleven manufacturing sites in seven countries that supply chemicals, plastics, and fibers products to customers.

Based out of Kingsport, TN, Eastman Chemical Co. has 15,000 employees and, after today’s trading, reached a market cap of $9.26 billion. The stock’s P/E Ratio is 12.3. Its P/S ratio is 1.22, P/B ratio is 2.39, and P/FCF ratio is 22.9.

For a complete fundamental analysis analysis of Eastman Chemical Co., check out Equities.com’s Stock Valuation Analysis report for EMN. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…


Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…